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The genus Burkholderia comprises more than 60 species able to adapt to a wide range
of environments such as soil and water, and also colonize and infect plants and animals.
They have large genomes with multiple replicons and high gene number, allowing these
bacteria to thrive in very different niches. Among the properties of bacteria from the
genus Burkholderia is the ability to produce several types of exopolysaccharides (EPSs).
The most common one, cepacian, is produced by the majority of the strains examined
irrespective of whether or not they belong to the Burkholderia cepacia complex (Bcc).
Cepacian biosynthesis proceeds by aWzy-dependentmechanism, and some of theB. cepa-
cia exopolysaccharide (Bce) proteins have been functionally characterized. In vitro studies
showed that cepacian protects bacterial cells challenged with external stresses. Regarding
virulence, bacterial cells with the ability to produce EPS are more virulent in several animal
models of infection than their isogenic non-producing mutants. Although the production of
EPS within the lungs of cystic ﬁbrosis (CF) patients has not been demonstrated, the in vitro
assessment of the mucoid phenotype in serial Bcc isolates from CF patients colonized for
several years showed that mucoid to non-mucoid transitions are relatively frequent. This
morphotype variation can be induced under laboratory conditions by exposing cells to
stress such as high antibiotic concentration. Clonal isolates where mucoid to non-mucoid
transition had occurred showed that during lung infection, genomic rearrangements, and
mutations had taken place. Other phenotypic changes include variations in motility, chemo-
taxis, bioﬁlm formation, bacterial survival rate under nutrient starvation and virulence. In
this review, we summarize major ﬁndings related to EPS biosynthesis by Burkholderia and
the implications in broader regulatory mechanisms important for cell adaptation to the
different niches colonized by these bacteria.
Keywords: exopolysaccharide, cepacian, biosynthesis, Burkholderia, cystic fibrosis, mucoid variation, virulence,
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INTRODUCTION
Extracellular polysaccharides or exopolysaccharides (EPSs) are
high-molecular weight sugar-based polymers that are synthe-
sized and secreted by many microorganisms. The importance of
their production has been studied in many bacteria. Typically
EPSs play a role in bacterial adaptation to different stress con-
ditions, being involved in the establishment of symbiotic and
pathogenic relationships with hosts and being suggested to be
a major component of bioﬁlm mature structures. The genus
Burkholderia also has the ability to produce EPS and at least
seven different exopolysaccharides have been identiﬁed and their
structure determined (Table 1). Some strains produce a single
exopolysaccharide while others produce mixtures. For example,
Burkholderia cepacia IST408 produces cepacian only (Cescutti
et al., 2000), but Burkholderia cenocepacia C9343 produces simul-
taneously PS-I, cepacian (PS-II), and α-1,6-glucan (Conway et al.,
2004). The most common EPS produced by Burkholderia is
cepacian and has been identiﬁed in different species, including
environmental isolates associated with plants and in both clinical
and environmental isolates from B. cepacia complex (Bcc; Ferreira
et al., 2010; Hallack et al., 2010). Furthermore, genes encod-
ing proteins involved in cepacian synthesis are well conserved
among Burkholderia, suggesting that cepacian is a common fea-
ture among the genus (Ferreira et al., 2010). Cepacian is composed
of a branched acetylated heptasaccharide repeat-unit with d-
glucose, d-rhamnose, d-mannose, d-galactose, and d-glucuronic
acid in the ratio of 1:1:1:3:1 (Cerantola et al., 1999; Cescutti et al.,
2000).
Cepacian production depends on external factors. For instance,
many strains unable to produce exopolysaccharide on LB medium
start to over-produce it in rich glucose- or mannitol-based
medium, such as S, SM, or YEM media (Richau et al., 2000a;
Bartholdson et al., 2008; Zlosnik et al., 2008). Also, the type of EPS
produced depends on external growth conditions as demonstrated
for the production of EPSA and EPS B by Burkholderia kururiensis
(Table 1;Hallack et al., 2010). These observations indicate that EPS
production by Burkholderia is tightly regulated as a response to
external conditions, which can be crucial in bacterial colonization
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Table 1 | Structural formula of the exopolysaccharide repeated units described in the literature.
EPS/species Structure Observations Reference
Cepacian (PS-II)/Bcc
and non-Bcc
Environmental and clinical
isolates; bce-I and bce-II genes
present in most Burkholderia
species; number of acetyl
groups is strain dependent
(two to four per RU)
Cerantola et al. (1999),
Cescutti et al. (2000),
Hallack et al. (2010)
PS-I/B. cepacia Clinical isolate Cerantola et al. (1996)
Levan/B. cepacia This strain produces an EPS
mixture that includes levan
Cescutti et al. (2003)
EPS A/B. kururiensis Endophytic diazotrophic
species
Mattos et al. (2001)
EPS B/B. kururiensis EPS B composed of a mixture
of two polymers: cepacian and
the octasaccharide polymer,
differing by the presence of a
terminal glycosyl residue
Hallack et al. (2010)
EPS/B. pseudomallei,
B. cepacia
One acetyl group per RU Nimtz et al. (1997),
Cescutti et al. (2003)
EPS/B. caribensis Isolated from rhizosphere and
important for soil aggregation
Vanhaverbeke et al.
(2001)
Main species from where different EPS were identiﬁed and relevant information associated with strain source or EPS characteristics is provided. Gal, galactose; Glc,
glucose; GlcA, glucuronic acid; Man, mannose; Rha, rhamnose; Fru, fructose; Kdo, 3-deoxy-D-manno-2-octulosonic acid; 6dTal, 6-deoxy-talose; OAc, acetyl substituent;
RU, repeat-unit.
and adaptation to different environments and hosts. Since cepa-
cian is the major EPS produced by Burkholderia, this review will
focus on the present knowledge concerning cepacian biosynthesis,
regulation, and possible importance in bacteria lifestyle.
GENES AND PROTEINS INVOLVED IN CEPACIAN
BIOSYNTHESIS
Genes involved in cepacian biosynthesis are located within bce-I
and bce-II gene clusters (Figure 1A; Moreira et al., 2003; Ferreira
et al., 2010). Comparative genomic studies indicate that the two
clusters are present in all sequenced Burkholderia genomes, with
the exception of the intracellular endosymbiotic Burkholderia rhi-
zoxynica HKI 454 with both gene clusters absent and Burkholderia
mallei having only bce-II. Isolates from these two species suffered
genomic size reduction and loss of many genes as indicated by
the 3.6-Mbp of B. rhizoxynica genome and the 5.2- to 5.9-Mbp
of B. mallei genomes in comparison with the 6.3- to 9.7-Mbp of
the genomes from the remaining Burkholderia species. Depend-
ing on the species, the two gene clusters can be located together
in the same genomic region or separated by hundreds of kilobase
pairs (Ferreira et al., 2010). The phylogenetic tree based on the
concatenation of all Bce protein sequences showed three distinct
groups (Figure 1B). Group I includes clinical and environmental
isolates from the Burkholderia cepacia complex, all of them hav-
ing the two bce clusters located apart from each other. Group
II contains animal and plant pathogenic non-Bcc isolates also
having the two clusters in different genomic locations. Group III
harbors non-pathogenic rhizosphere and plant-associated strains
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FIGURE 1 | Genes and proteins involved in cepacian biosynthesis.
(A) Genetic organization of bce-I and bce-II clusters of genes encoding
proteins involved in cepacian biosynthesis.With exception of B.
xenovorans, B. phymatum, B. phytoﬁrmans, B. graminis, Burkholderia sp.
H160 and sp. CCGE 1003, in most of Burkholderia species, the two clusters
are located approximately 155–314 kb apart in the genome. (B)
Neighbor-joining phylogenetic tree of the deduced amino acid sequences of
Bce predicted proteins from 16 strains of Burkholderia distributed by 14
species. The several Bce protein sequences of each species were
concatenated and were aligned by CLUSTALX 2.0 using 1000 bootstrap
replicates and sorted byTreeView 1.6.6. The clusters obtained allow the
distinction of Bcc strains (group I) from non-Bcc strains having the bce
genes clustered separately (group II) or together (group III) in their
genomes. Scale: number of substitutions per site.
having bce-I and bce-II gene clusters together. The rice pathogen
Burkholderia glumae BGR1, evolutionarily close to groups I and
II strains, also has the bce gene clusters into different genomic
locations.
Cepacian biosynthesis starts with the formation of activated
sugar-nucleotide precursors required for the synthesis of the
repeat-unit building blocks (Figure 2A; Richau et al., 2000b).
Several of the enzymes involved in the process are encoded
within the bce-I and bce-II gene clusters. Gene bceA encodes a
bifunctional protein providing the ﬁrst and third steps (phos-
phomannose isomerase and GDP-d-mannose pyrophosphory-
lase activities) for converting fructose-6-phosphate from cen-
tral metabolism into GDP-d-mannose (Figure 2A; Sousa et al.,
2007a, 2008). A bceA gene insertion mutant was still capable
of producing half the amount of EPS of the parental strain B.
cepacia IST408, showing that other enzymes producing GDP-d-
mannose are present in this microorganism (Sousa et al., 2007a).
Gene bceC encodes a UDP-glucose dehydrogenase responsible
for the NAD-dependent twofold oxidation of UDP-d-glucose to
UDP-d-glucuronic acid (Loutet et al., 2009). Its 3D-structure
was recently determined and the tyrosine residue at position 10
was found to be the key catalytic residue in the ﬁnal hydrolysis
FIGURE 2 | Biosynthesis of the exopolysaccharide cepacian by
Burkholderia. (A) Metabolic route toward the synthesis of the various
activated sugar-nucleotide precursors required for cepacian repeat-unit
biosynthesis. (B) Schematic representation of enzymes involved in
cepacian biosynthesis. Repeat-units of the polymer are assembled on a
isoprenoid lipid carrier, in the cytoplasmic side of inner membrane in a
reaction initiated by the BceB enzyme and continued by the other
glycosyltransferases BceG, BceH, BceJ, BceK, and BceR and putative
acyltransferases BceO, BceS and BceU. The lipid-linked repeat-units are
translocated across the inner membrane by the putative BceQ membrane
protein. Polymerization occurs at the periplasmic face of the inner
membrane and is dependent on another membrane protein, the putative
polysaccharide polymerase, BceI. Wzy-dependent polymerization/export
requires the activity of the BceF tyrosine kinase. BceD is a protein tyrosine
phosphatase enzyme responsible for dephosphorylating BceF. BceE forms
a channel structure for export of EPS chains to the outside. BceP, putatively
involved in polysaccharide degradation, is depicted as associated to the
outer membrane, as one of its possible locations. Glc, glucose; GlcA,
glucuronic acid; Gal, galactose; Rha, rhamnose; Man, mannose; Fru,
fructose; GDP, guanosine-5′-diphosphate; UDP, uridine-5′-diphosphate;
PGM, phosphoglucomutase; UGP, UDP-glucose pyrophosphorylase; UGD,
UDP-glucose dehydrogenase; UGE, UDP-glucose epimerase; PGI,
phosphoglucose isomerase; PMI, phosphomannose isomerase; PMM,
phosphomannomutase; GMP, GDP-D-mannose pyrophosphorylase; GRS,
GDP-rhamnose synthase; ATP, adenosine-5′- triphosphate; ADP,
adenosine-5′- diphosphate; YP, phosphorylated tyrosine residue; Pi,
inorganic phosphate; IM, inner membrane; OM, outer membrane; PL,
peptidoglycan layer.
of the enzymatic thioester intermediate (Rocha et al., 2011).
Although there is no experimental demonstration, bceT gene
product must provide the activity of UDP-glucose pyrophos-
phorylase for the synthesis of UDP-d-glucose and bceN and
bceM gene products provide the activities of GDP-mannose-
4,6-dehydratase (GMD) and a GDP-6-deoxy-d-lyxo-4-hexulose
reductase (RMD) for GDP-d-rhamnose synthesis (Figure 2A; Fer-
reira et al., 2010). The genes encoding the enzymes UDP-glucose
epimerase required for the formation of UDP-d-galactose and
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phosphoglucomutase (PGM), phosphoglucose isomerase (PGI),
and phosphomannomutase (PMM) required for the synthesis
of some of the intermediary precursors are absent from bce-I
and bce-II gene clusters. Since the products of these enzymatic
reactions are involved in other polysaccharide biosynthetic path-
ways, these enzyme-encoding genes are located elsewhere in the
genome. In silico analysis using B. cenocepacia J2315 genome
sequence shows that BCAL3113 encodes an enzyme with the puta-
tive function of PGM and PMM; BCAL1990 encodes the putative
PGI enzyme; and BCAL3117 encodes a putative UDP-glucose
epimerase.
The synthesis of the activated sugar-nucleotide precursors is
followed by the assembly of the heptasaccharide repeat-unit, cat-
alyzed by glycosyltransferase proteins encoded by bceB,bceG,bceH,
bceJ, bceK, and bceR genes (Figure 2B). BceB is an inner mem-
brane protein that catalyzes the transfer of glucose-1-phosphate
to the isoprenoid lipid carrier (Videira et al., 2005). The speciﬁc
sugar added by the remaining Bce glycosyltransferases has not yet
been identiﬁed. BceG is predicted to belong to the CAZy GT-2
family of enzymes that transfer glycosyl residues by an inverting
mechanism and adopt a GT-A fold having a single Rossmann-like
domain for nucleotide binding (Coutinho et al., 2003). BceH,BceJ,
and BceK are predicted to belong to CAZy GT-1 family, which
comprises retaining glycosyltransferases that adopt a GT-B fold
characteristic of proteins that have two Rossmann-like domains.
The protein encoded by bceR gene is predicted to be a bifunctional
enzyme with two glycosyltransferase domains of CAZy GT-4 fam-
ily with a retaining mechanism of glycosyl residue transfer and
adopting a GT-B fold. BceR has been shown to be essential for
cepacian biosynthesis, as conﬁrmed by the absence of exopolysac-
charide in the growth medium of B. cepacia IST408 bceR gene
insertion mutant (Ferreira et al., 2010). BceG, BceH, and BceR
are probably cytoplasmic proteins, whereas BceJ and BceK are
likely to possess a transmembrane domain, being integral mem-
brane proteins. The order of sugar addition to the repeat-unit
has been proposed (Cescutti et al., 2010) with the glucuronic acid
being added to a trisaccharide composed of glucose and mannose
substituted with galactose; then a second galactose is added to
the glucuronic acid as the ﬁrst substituent, followed by a rham-
nose and galactose, as a second disaccharide substituent (Cescutti
et al., 2010). Cepacian acetylation is predicted to occur during
the repeat-unit assembly process, but the number of substitu-
tions is strain dependent (Cescutti et al., 2010). The enzymes
required for these modiﬁcations are putatively encoded by bceS,
bceT, and bceU genes and are predicted to be located in the inner
membrane. BceO and BceU exhibit nine predicted transmem-
brane domains, while BceS exhibits eight predicted transmem-
brane domains (Figure 2B; Ferreira et al., 2010). Despite a weak
conservation at the amino acid level, BceO, BceS, and BceU are
homologous to a series of proteins that deﬁne a family of mem-
brane proteins involved in the acylation of carbohydrate moieties
of extracytoplasmic molecules. An insertion mutant on bceS gene
showed a reduction of the acetylation content of the EPS produced
by B. multivorans ATCC 17616 by approximately 20%,which con-
ﬁrms BceS involvement in the repeat-unit modiﬁcation (Ferreira
et al., 2010).
The steps after repeat-unit assembly are polymerization and
export of the exopolysaccharide to the cell’s surrounding. Avail-
able data indicates the assembly proceeds via the so-called Wzy-
dependent pathway (Figure 2B). According to thismodel, the lipid
carrier-linked heptasaccharide repeat-units are exported across
the inner membrane by a ﬂippase protein and polymerized at
the periplasmic face of the inner membrane by a polysaccha-
ride polymerase. Since the proteins encoded by bceQ and bceI
genes, have 12 and 10 transmembrane domains, respectively, and
show similarity with other Wzx ﬂippases and Wzy polysaccha-
ride polymerases, we postulated that BceI is the putative poly-
merase and BceQ the putative ﬂippase. Both genes are essential
for cepacian biosynthesis, as demonstrated by the EPS deﬁcient
phenotype of the B. cepacia IST408 insertion mutants for bceI
and bceQ genes (Moreira et al., 2003; Ferreira et al., 2010). The
proteins encoded by bceD and bceF genes are also involved in
the EPS polymerization and export process (Figure 2B). BceF
belongs to the bacterial tyrosine kinase (BY-kinase) family which
includes Wzc homologs predicted to act as the polysaccharide
copolymerase component (Whitﬁeld, 2006). BceF possesses two
transmembrane domains that ﬂank a large periplasmic domain
and a cytoplasmic located C-terminal region. The periplasmic
domain is predicted to adopt a coiled-coil structure impor-
tant for interaction with other protein (such as BceE). Tocilj
et al. (2008) propose that this periplasmic domain is the one
affecting polysaccharide chain length, and that by interacting
with the export component facilitates transfer of the polymer
through the periplasm. The C-terminal cytoplasmic domain of
BceF has the conserved Walker A and Walker B ATP-binding
motifs and a tyrosine-rich cluster (Moreira et al., 2003; Ferreira
et al., 2007). Site-directed mutagenesis was used to conﬁrm the
importance of the Walker A motif on BceF tyrosine autophos-
phorylation activity (Ferreira et al., 2007), but the role of tyro-
sine phosphorylation in cepacian biosynthesis is unknown. BceD
is a phosphotyrosine phosphatase (PTP) protein that interacts
with BceF, promoting the BY-kinase tyrosine dephosphoryla-
tion (Ferreira et al., 2007). BceE is a putative Wza homolog
and therefore is predicted to be an outer membrane polysac-
charide export protein (OPX) responsible for the ﬁnal stage of
polysaccharide export. OPX family of proteins are predicted to
be lipoproteins that adopt an octameric conﬁguration with a
large central cavity that facilitates polysaccharide export through
the periplasm and across the outer membrane (Dong et al.,
2006). A B. cepacia IST408 bceE mutant is impaired in cepa-
cian biosynthesis demonstrating the importance of this protein
in the biosynthesis of this polymer (our unpublished data).
Finally, bce-II gene cluster contains the bceP gene, encoding a
protein of unknown function. BceP secondary structure was pre-
dicted to be exclusively composed of β-strands, and its location
is unlikely the cytoplasm. It can be the periplasm, the outer
membrane, or even the extracellular milieu. Structural homology
modeling suggests that BceP resembles polysaccharide degrading
enzymes such as Clostridium thermocellum xyloglucanase (PDB
entry: 2cn2). Thus, BceP may be responsible for processing the
polysaccharide before and/or after export depending on its cellular
localization.
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REGULATION OF CEPACIAN BIOSYNTHESIS
Although the bce-I and bce-II gene clusters encode most of the
structural proteins required for cepacian biosynthesis, the genes
directly involved in the regulation of EPS production have not
been identiﬁed. While algU and mucA genes encode a transcrip-
tion factor and anti-sigma factor, respectively, responsible for
the control of the alginate biosynthetic operon in Pseudomonas
aeruginosa (Ramsey and Wozniak, 2005), the B. cepacia AlgU
homolog (RpoE) is not required for exopolysaccharide biosyn-
thesis as demonstrated for a rpoE knockout mutant (Devescovi
and Venturi, 2006). Although the mechanisms/players involved
in the regulation of cepacian biosynthesis are unclear, there are
evidences of the involvement of quorum sensing (QS) regula-
tion at transcriptional level and protein tyrosine phosphoryla-
tion/dephosphorylation at post-translational level.
Recent studies on the plant-associated B. kururiensis M130, B.
xenovorans LB400,andB. uname MTI-641 indicate that theN -acyl
homoserine lactones (AHL) synthase BraI and the QS transcrip-
tional regulator BraR are involved in the regulation of EPS biosyn-
thesis. The mutants obtained for braI and braR genes were less
mucoid and the total sugar content of the growth culture decreased
considerably (Suarez-Moreno et al., 2010). This phenotype could
be reversed by external supplementation of 3-oxo-C14-HSL or 3-
oxo-C12-HSL, depending on the species (Suarez-Moreno et al.,
2010). Such results conﬁrm that QS positively controls EPS pro-
duction in these plant-associated species, still the targets of such
regulation cascade are unknown. Furthermore, the BraI/R system
is not conserved in theBurkholderia genus and3-oxo-AHLs are not
produced by many species. For instance, in Bcc bacteria, the most
well conserved QS system consists of CepI and CepR which pro-
duces and responds to C6-HSL and C8-HSL (Sokol et al., 2003).
Whether CepI/CepR system mediated QS is able to regulate EPS
production in the different Bcc species still needs conﬁrmation.
Another mechanism that may be involved in regulating cepa-
cian biosynthesis at the transcriptional level is mediated by the
RNA chaperone Hfq. This protein is involved in the regulation
of target mRNAs by small regulatory non-coding RNAs (Sousa
et al., 2010). Deletion of hfq gene of B. cepacia IST408 strongly
reduces cepacian production. Whether a small RNA molecule is
directly responsible for this phenotype or is a consequence of
the pleiotropic effects caused by loss of this gene still has to be
determined.
Regarding post-translational regulation, it is established that
cycles of tyrosine phosphorylation and dephosphorylation, medi-
ated by BY-kinases and PTP proteins, control the amount and
the molecular weight of several bacterial exopolysaccharides (Vin-
cent et al., 2000; Wugeditsch et al., 2001). However, the exact
mechanism of such regulation is not clear. One hypothesis is
that the BY-kinase tyrosine phosphorylation/dephosphorylation
cycles interfere with the interaction with the outer membrane
export OPX proteins by introducing conformational changes
in the BY-kinase/OPX complex, perhaps affecting polymeriza-
tion and/or export of the polysaccharide to the cell surround-
ing (Collins et al., 2006). Alternatively, BY-kinases may phos-
phorylate exogenous substrates, including proteins involved in
sugar-nucleotide precursor’s formation and repeat-unit assembly,
thereby controlling their activity and consequently polysaccha-
ride production. This was shown for colanic acid biosynthe-
sis in E. coli in which the UDP-glucose dehydrogenase pro-
tein is phosphorylated by the Wzc BY-kinase, inﬂuencing the
amount of EPS (Lacour et al., 2008). In Streptococcus ther-
mophilus the EPS priming glycosyltransferase EpsE was shown
to be regulated by the tyrosine kinase EpsD (Minic et al., 2007).
Concerning cepacian biosynthesis, the disruption of the bceF
gene abolishes cepacian production, while the bceD mutant
shows a reduction of about 25% of cepacian production, and
the EPS has a lower molecular weight than that produced by
the parental strain (Ferreira et al., 2007). Therefore, BceF BY-
kinase and BceD PTP protein may be involved in the regu-
lation of the amount and molecular weight of cepacian, even
though there are no studies available regarding their exact role
in polymerization/export or in regulating the activity of the
enzymes involved in sugar-nucleotide precursors biosynthesis and
repeat-unit assembly.
ROLE OF BURKHOLDERIA EXOPOLYSACCHARIDES IN
ADAPTATION TO DIFFERENT NICHES
Bacterial extracellular polysaccharides have been described as
pathogenicity determinants in humans, livestock, and plant infec-
tions; as important in the establishment of symbiotic interactions
between bacteria and plants; and as a barrier to harmful com-
pounds (Fraysse et al., 2003; Lebeer et al., 2011; Nielsen et al.,
2011).Depending on the ecological niche, exopolysaccharides help
bacteria to colonize different environments. Given that cepacian
is ubiquitous in the genus Burkholderia, it would be expected that
this EPS plays an important role in bacterial adaptation to different
conditions including host/bacteria interactions. Figure 3 summa-
rizes the current knowledge on the relevance of exopolysaccharides
in Burkholderia biology. Interaction between plants and bacteria is
often correlated to the ability of bacteria to produce EPSs, regard-
less beingpathogenic or symbiotic. Inpathogenic interactions,EPS
contributes to the initial plant colonization and enhances bacteria
survival within the plant host tissues during the course of infec-
tion, as described for Agrobacterium, Erwinia, and Pseudomonas
(Denny, 1995). On the other hand, EPSs are important in the
establishment of symbiotic interactions such as in biological nitro-
gen ﬁxation symbiosis between rhizobia and leguminous plants
FIGURE 3 | Roles of Burkholderia exopolysaccharides in the adaptation
to different niches.
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(Gonzalez et al., 1996). Since the ﬁrst description of pathogenicity
in the Bcc bacteria was based on sour skin rot of onion bulbs,
Bartholdson et al. (2008) investigated EPS production in Bcc iso-
lates and their onion-associated phenotype. Although the onion
carbohydrates induced EPS production, no correlation between
exopolysaccharide production ability of the tested strains and tis-
sue onion maceration was found. Therefore, a possible role of the
exopolysaccharides in interaction between Burkholderia and host
plants has yet to be demonstrated. Nevertheless, the observation
that the endophyticB. kururiensis exopolysaccharides can bemod-
ulated under growth conditions is potentially signiﬁcant in terms
of a possible endophytic-host plant interaction and further studies
are needed (Hallack et al., 2010).
Since many exopolysaccharides are high-molecular weight
polymers, they form a hydrated anionic matrix that surrounds
the cell protecting bacteria against environmental stresses. Also,
the hygroscopic properties of the EPS may reduce the rate of
water loss from cells and provide bacteria with means to survive
drying and desiccation (Potts, 1994). A study performed with B.
xenovorans LB400 and B. multivorans ATCC 17616 isolates has
shown that the external supplementation of cepacian enhanced
their desiccation tolerance when compared to a condition where
no exopolysaccharide was present (Ferreira et al., 2010). Cepacian
also protects Burkholderia cells against metal ion stress, namely
high concentration of Fe2+ and Zn2+ (Ferreira et al., 2010). The
metal-binding properties of EPS might be due to the occurrence
of carbonyl, carboxyl, and hydroxyl groups within the EPS matrix
that can complex cations and scavenge metals (Potts, 1994). The
ability of Burkholderia strains to withstand desiccation and metal
ion stress in the presence of the cepacian is an indication that this
EPS may play a role in survival, thus representing an advantage for
bacteria to thrive in adverse environments.
Exopolysaccharides inﬂuence the stability of soil aggregates
by interacting with clay particles contributing to maintain the
mechanical and physical properties of the soil onwhich plant roots
are grown. Vanhaverbeke et al. (2003) used the exopolysaccharide
produced by Burkholderia caribensis MWAP71 to determine the
interactions between the polysaccharide and the soil at the molec-
ular level and one of the hypothesis raised is that the disorganized
conformations of the exopolysaccharide connects several clay lay-
ers, resulting in a network composed by clays partially dispersed
within an EPS matrix, which enhances the hydration properties of
the whole soil.
Burkholderia exopolysaccharides, particularly cepacian, was
postulated as a virulence determinant of Bcc species infecting
the airways of cystic ﬁbrosis (CF) patients and its importance in
pathogenicity was assessed by several in vitro and in vivo studies.
For instance, infection of a BALB/c mouse pulmonary infection
model with two clonal isolates of B. cenocepacia obtained from
a CF patient and displaying a different morphotype (mucoid vs.
non-mucoid) showed that the mucoid isolate persisted longer in
the lungs (Conway et al., 2004). Similarly, the infection of the
gp91phox−/− mouse with EPS-producing bacteria of the species B.
cepacia showed that the EPS-producing strain B. cepacia IST408
caused higher mice mortality than the non-EPS producer isogenic
bceF and bceI mutants (Sousa et al., 2007b). In vitro studies con-
ﬁrmed the ability of Burkholderia exopolysaccharides to interfere
with the innate immune system by neutralizing reactive oxygen
species (Bylund et al., 2006), inhibiting neutrophil chemotaxis and
interfering with phagocytosis of bacteria by human neutrophils
(Conway et al., 2004; Bylund et al., 2006). The interference by the
EPS in phagocytosis could possibly be explained by the masking of
bacterial surface antigens recognized by immune cells. Although
these data suggest that exopolysaccharides enhance bacterial vir-
ulence, there is no experimental demonstration of Bcc bacteria
producing it within the lungs. In addition, EPSs are not the only
virulence factor in Bcc since the most hostile strains, responsi-
ble for major clinical outbreaks and associated to a worst clinical
outcome that includes the development of cepacia syndrome, are
non-mucoid (Govan et al., 1993). Supporting this, a recent sur-
veillance study showed that patients infected with non-mucoid
Bcc strains experience a more rapid lung function decline (Zlos-
nik et al., 2011). Still,most of the clinical isolates fromdifferentBcc
species, with the exception of B. cenocepacia, are able to produce
exopolysaccharide (Zlosnik et al., 2008).
Another import role attributed to polysaccharides is the medi-
ation of bacterial resistance against antimicrobial peptides pro-
duced by epithelial and phagocytic cells. A study involving the
human antimicrobial peptides cathelicidin LL-37 and β-defensin
hBD-3 as well as peptides from other mammals demonstrated that
the antibacterial activity of these different peptides was consider-
ably decreased in the presence of polysaccharides produced by
the lung pathogens P. aeruginosa, Klebsiella pneumoniae, and Bcc
members (Benincasa et al., 2009). Production of bacterial polysac-
charides in the lungs of CF patients could contribute to a decreased
efﬁcacy of the host defense response and the concomitant estab-
lishment of a persistent infection by these bacteria.
Exopolysaccharides, proteins, and DNA are the main con-
stituents of the mature bioﬁlm matrix contributing for example
to the persistence of chronic P. aeruginosa lung infections in CF
patients (Hentzer et al., 2001). Bacterial bioﬁlms cause chronic
infections due to their increased tolerance to antibiotics and resis-
tance to the immune system phagocytic cells. As a consequence,
chronic inﬂammation develops, being the major cause of the
lung tissue damage in CF (Hoiby et al., 2010). Bcc bacteria were
also shown to produce bioﬁlms in abiotic surfaces and on well-
differentiated human epithelial cells (Schwab et al., 2002) and the
production of bioﬁlms associated to a signiﬁcant increase of resis-
tance against the host immune system and antibiotic treatment
in Burkholderia (Caraher et al., 2007). Mutants constructed on
bce genes have conﬁrmed the importance of cepacian in the for-
mation of mature bioﬁlms. Mutants unable to produce cepacian,
such as a bceF insertion mutant, or mutants that produce a lower
molecular weight form, such as bceD insertion mutant, exhibited
a much thinner bioﬁlm when compared to the one produced by
the parental strain (Ferreira et al., 2007). Therefore, it has been
hypothesized that by promoting the formation of mature bioﬁlms,
the EPS may enhance bacterial survival in CF lung, which leads to
the impossibility to efﬁciently eradicate Bcc infections.
EMERGENCE OF BURKHOLDERIA MORPHOTYPE VARIATION
DURING CHRONIC LUNG INFECTIONS
The initial colonization of CF lungs by P. aeruginosa is made
by environmental strains that during the course of infection
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developed the mucoid phenotype caused by production of algi-
nate (Pedersen et al., 1992). To evaluate whether Burkholderia
shows such variation during lung colonization, 560 Bcc sequen-
tial isolates recovered from 100 CF patients were screened for
EPS production by analyzing their mucoid phenotype in EPS-
producing medium (Zlosnik et al., 2008). Fifteen mucoid pheno-
typic transitions were observed: 13 from mucoid-to-non-mucoid
were detected in B. multivorans,B. cenocepacia, and B. vietnamien-
sis; and two non-mucoid-to-mucoid transitions occurred in B.
cenocepacia and B. vietnamiensis (Zlosnik et al., 2008). Further
insights into the importance of this morphotypic variation in
adaptation to lung environment came from two pairs of sequen-
tial isolates recovered from patients chronically infected for several
years. The ﬁrst pair of sequential isolates characterized was from
B. cenocepacia and the isolates were recovered within 10months of
each other (Conway et al., 2004). These isolates showed genomic
alterations as visible by their genome SpeI-restriction pattern, by
mutations in the QS regulator encoding gene cepR and deletion
of a region from the pathogenicity island present in the mucoid
isolate (Zlosnik and Speert, 2010; McKeon et al., 2011). In addi-
tion, the mucoid isolate had decreased expression of virulence
factors such as the nematocidal protein AidA or the zinc metal-
loprotease ZmpA, was less resistant to oxidative stress, produced
less bioﬁlm, but showed a lower clearance rate from the lungs of
BALB/c mice when compared to the clonal non-mucoid isolate
(Conway et al., 2004; Zlosnik and Speert, 2010). The second pair
of clonal sequential isolates belongs to B. multivorans and the iso-
lates recovered within a 6-month period. The mucoid isolate had
decreased long-term survival rate in nutrient depleted medium,
produced less bioﬁlm, had increased expression of virulence-
associated genes, higher growth rate under microaerophilic con-
ditions, increased motility, and was shown to be more virulent in
Galleria mellonella (Silva et al., 2011). Since only two pairs of iso-
lates with a mucoid vs. non-mucoid morphotype were evaluated it
is early to take conclusions about the typical phenotypic proﬁle of
the non-mucoid isolates arising during chronic respiratory lung
infections. Nevertheless, it is evident that the emergence of mucoid
vs. non-mucoidmorphotype variation in the lung of CF patients is
correlated with metabolic changes, different survival ability under
stress conditions, altered bioﬁlm formation, motility, chemotaxis,
and virulence (Figure 4).
The relationship of mucoidmorphotype variationwithin adap-
tation to the lung environment and disease progression is not yet
known. If EPS-producing bacteria could be favored to persist in
the lungs by avoiding the immune system, it is also true that the
non-EPS producers, by their ability to produce more bioﬁlm and
displaying higher survival rate under nutrient limitation, may be
adapted as well to persist in the lungs. As regards the virulence
potential of the mucoid and non-mucoid clonal isolates, the data
obtained so far for mice and insects showed that the mucoid iso-
lates were more virulent (Conway et al., 2004; Silva et al., 2011).
Nevertheless, these data report to two isolates only and no ulti-
mate conclusion about their virulence potential can be made.
Besides, a study focused on the virulence potential of mucoid
and non-mucoid clinical isolates in CF patient’s lung function
decline, suggested that patients infected with non-mucoid isolates
had worst prognosis (Zlosnik et al., 2011).
FIGURE 4 | Bacterial phenotypes displaying variation during Bcc
mucoid vs. non-mucoid transition that occurs in persistently colonized
lungs of cystic fibrosis patients.
The cues triggering mucoid morphotype variation of Bcc
during their persistence in the CF lung remain unknown. The
only in vitro condition described so far that induces B. ceno-
cepacia mucoid vs. non-mucoid transition is high doses of the
antibiotics ceftazidime and ciproﬂoxacin (Zlosnik et al., 2011).
As regards the molecular mechanisms behind the morphotype
variation they are completely unidentiﬁed. During chronic lung
infection genomic alterations including point mutations, deletion,
and duplication of genes arise as it was found for the two pairs of
Bcc isolates where the mucoid morphotype variation was char-
acterized (Zlosnik and Speert, 2010; Silva et al., 2011). Whether
these alterations are responsible for the observed phenotypes is
unknown.
CONCLUDING REMARKS
The genus Burkholderia has the genetic capacity to produce sev-
eral different secreted extracellular polysaccharides, although only
cepacian biosynthetic mechanisms have been studied with some
detail by the identiﬁcation of the genes involved and character-
ization of some of the Bce proteins. However, no information
exists regarding genetics and regulation of other polysaccharides
identiﬁed in Burkholderia, some of which are often coexpressed
with cepacian. The ability of Burkholderia to produce different
exopolysaccharides raises questions on which environmental sig-
nals induce production of one polysaccharide vs. others and their
speciﬁc roles to provide a survival advantage in different ecological
niches such as soil, water, or during host/bacteria interactions. In
particular, efforts have been made to understand the relevance of
EPS production in virulence and persistence of Bcc bacteria in CF
lung,but the role of EPS inBurkholderia virulence remains anopen
issue. While some evidences point out to EPS as a virulence factor,
others indicate a major role in persistence. Furthermore, during
the course of chronic lung infection genotypic and mucoid mor-
photype variation occurs, with clonal isolates displaying different
phenotypes and virulence levels. This shows that EPS biosynthesis
can be critical duringBurkholderia lung infection, likely as part of a
complex regulation network interfering with many other bacterial
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properties that change during infection and represent important
bacterial adaptations to the CF lung. Further research is needed
to understand the conditions that trigger such phenotypic conver-
sions aswell as the regulatorymechanisms underlying the cepacian
biosynthesis.
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